By
BioVersys AG
Published: May 7, 2024, 8:59 p.m.·
Tags:
Research and development,
Medicines
BioVersys AG announced the expansion of its strategic collaboration with GSK plc to accelerate the clinical development of alpibectir (BVL-GSK098) for the treatment of TB.
Read More →